No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1, A Building Block of HDL Cholesterol
DAIC
APRIL 6, 2024
However, in an exploratory analysis of outcomes, treated patients had fewer heart attacks and heart-attack deaths than patients in the control group at six months, he said. People who have had a heart attack are at high risk for another one, especially during the next 90 days, Gibson said.
Let's personalize your content